Reference number : 236-2018-2019-Q1-00140, amendment number : , agreement type : G, recipient legal name : Kibel, Seth G, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M5G 1X8, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 5000.0, agreement start date : 2018-05-01, agreement end date : 2018-08-31, description english : Controlled gene editing with the TevSaCas9 dual nuclease system as a potential therapy for Duchenne muscular dystrophy, description french : Controlled gene editing with the TevSaCas9 dual nuclease system as a potential therapy for Duchenne muscular dystrophy, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada